| human | Q5 |
| P496 | ORCID iD | 0000-0002-9706-0514 |
| P69 | educated at | University of Sydney | Q487556 |
| P108 | employer | Peter MacCallum Cancer Centre | Q7175569 |
| Garvan Institute of Medical Research | Q5524507 | ||
| P735 | given name | Mandy | Q283277 |
| Mandy | Q283277 | ||
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | female | Q6581072 |
| Q36029709 | A Genome-Wide Scan Identifies Variants in NFIB Associated with Metastasis in Patients with Osteosarcoma |
| Q35958026 | An increased incidence of Hodgkin's lymphoma in patients with adult-onset sarcoma. |
| Q38996690 | Clinical implications of genomics for cancer risk genetics |
| Q52875169 | Diagnosis and Management of Hereditary Sarcoma. |
| Q38764208 | Estimating TP53 Mutation Carrier Probability in Families with Li-Fraumeni Syndrome Using LFSPRO. |
| Q38261826 | Etiologic, environmental and inherited risk factors in sarcomas. |
| Q54505447 | Genistein inhibits PDGF-stimulated proteoglycan synthesis in vascular smooth muscle without blocking PDGFβ receptor phosphorylation. |
| Q46826550 | Glycated and carboxy-methylated proteins do not directly activate human vascular smooth muscle cells. |
| Q45938367 | Growth factor-mediated hyper-elongation of glycosaminoglycan chains on biglycan requires transcription and translation. |
| Q37033772 | High frequency of germline TP53 mutations in a prospective adult-onset sarcoma cohort |
| Q34548738 | Imatinib inhibits vascular smooth muscle proteoglycan synthesis and reduces LDL binding in vitro and aortic lipid deposition in vivo |
| Q46061185 | Inherited and de novo germline TP53 mutations in adult-onset sarcoma |
| Q59270796 | Inherited and de novo germline TP53 mutations in adult-onset sarcoma |
| Q48858319 | International survey of awareness of genetic risk in the clinical sarcoma community |
| Q38197030 | Li-Fraumeni syndrome: cancer risk assessment and clinical management |
| Q32491318 | Monogenic and polygenic determinants of sarcoma risk: an international genetic study |
| Q55177689 | New approaches to regulating the chondroitin/dermatan sulfate glycosaminoglycan component of the vascular extracellular matrix. |
| Q42976970 | PDGF beta-receptor kinase activity and ERK1/2 mediate glycosaminoglycan elongation on biglycan and increases binding to LDL. |
| Q55691375 | Pathogenic germline TP53 mutations in adult sarcoma patients; implications for treatment and screening – description of an upcoming project. |
| Q67231109 | Patient perspectives on molecular tumor profiling: "Why wouldn't you?" |
| Q33747946 | Platelet-derived growth factor differentially regulates the expression and post-translational modification of versican by arterial smooth muscle cells through distinct protein kinase C and extracellular signal-regulated kinase pathways |
| Q47369258 | Psychosocial morbidity in TP53 mutation carriers: is whole-body cancer screening beneficial? |
| Q39912303 | Pyrido-pyrimidine derivative CYC10424 inhibits glycosaminoglycan changes on vascular smooth muscle-derived proteoglycans and reduces lipoprotein binding. |
| Q42509038 | Regulation of the atherogenic properties of vascular smooth muscle proteoglycans by oral anti-hyperglycemic agents. |
| Q54046401 | Sarcoma and germ-line DICER1 mutations - Authors' reply. |
| Q80556334 | Smad and p38 MAP kinase-mediated signaling of proteoglycan synthesis in vascular smooth muscle |
| Q85015585 | Smad2-dependent glycosaminoglycan elongation in aortic valve interstitial cells enhances binding of LDL to proteoglycans |
| Q38958391 | Sociodemographic, psychosocial and clinical factors associated with uptake of genetic counselling for hereditary cancer: a systematic review |
| Q46203810 | Suramin inhibits PDGF-stimulated receptor phosphorylation, proteoglycan synthesis and glycosaminoglycan hyperelongation in human vascular smooth muscle cells. |
| Q30967044 | Surveillance recommendations for patients with germline TP53 mutations. |
| Q43137840 | TGF-beta stimulates biglycan synthesis via p38 and ERK phosphorylation of the linker region of Smad2. |
| Q55243290 | The PiGeOn project: protocol of a longitudinal study examining psychosocial and ethical issues and outcomes in germline genomic sequencing for cancer. |
| Q37116458 | The attitudes of people with sarcoma and their family towards genomics and incidental information arising from genetic research |
| Q36470928 | Timing and context: important considerations in the return of genetic results to research participants |
| Q91049763 | Who should access germline genome sequencing? A mixed methods study of patient views |
Search more.